L.G.H Medical Specialities Profile
Key Indicators
- Authorised Capital ₹ 3.60 Cr
as on 17-06-2024
- Paid Up Capital ₹ 3.01 Cr
as on 17-06-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.33 Cr
as on 17-06-2024
- Revenue 46.66%
(FY 2023)
- Profit 70.11%
(FY 2023)
- Ebitda 71.52%
(FY 2023)
- Net Worth 21.30%
(FY 2023)
- Total Assets 38.60%
(FY 2023)
About L.G.H Medical Specialities
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 3.01 Cr.
The company currently has active open charges totaling ₹1.33 Cr.
Naga Cheela, Sirisha Nemani, and Nitesh Nemani serve as directors at the Company.
- CIN/LLPIN
U74999AP2017PTC107303
- Company No.
107303
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at L.G.H Medical Specialities?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Cheela  | Director | 02-Sep-2022 | Current |
| Sirisha Nemani | Director | 02-Sep-2022 | Current |
| Nitesh Nemani | Director | 08-Jul-2022 | Current |
Financial Performance of L.G.H Medical Specialities.
L.G.H Medical Specialities Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.66% increase. The company also saw a substantial improvement in profitability, with a 70.11% increase in profit. The company's net worth Soared by an impressive increase of 21.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of L.G.H Medical Specialities?
In 2023, L.G.H Medical Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indikhaa Natural Foods & Beverages Private LimitedActive 2 years 11 monthsNitesh Nemani is a mutual person
Charges (Loans)
₹1.33 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 1.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | Others | ₹1.00 Cr | Open |
| 22 Dec 2022 | Others | ₹3.26 M | Open |
How Many Employees Work at L.G.H Medical Specialities?
L.G.H Medical Specialities has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of L.G.H Medical Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped L.G.H Medical Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
